NPM1 Minimal Residual Disease Detection at Any Time by Clinical Next Generation Sequencing Predicts Poor Survival in Acute Myeloid Leukemia

被引：0
|
作者：
Sallman, D. [1 ]
Xie, Z. [1 ]
Chan, O. [1 ]
Shao, R. [2 ]
Song, J. [2 ]
Hussaini, M. O. [2 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Malignant Hematol, Tampa, FL USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Pathol & Lab Med, Tampa, FL USA
来源：
AMERICAN JOURNAL OF CLINICAL PATHOLOGY | 2024年 / 162卷
关键词：
D O I：
10.1093/ajcp/aqae129.182
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
aqae129.18
引用
收藏
页码：S83 / S83
页数：1
相关论文
共 50 条
  • [31] Minimal Residual Disease Monitoring of Acute Myeloid Leukemia by Massively Multiplex Digital PCR in Patients with NPM1 Mutations
    Mencia-Trinchant, Nuria
    Hu, Yang
    Alas, Maria Antonina
    Ali, Fatima
    Wouters, Bas J.
    Lee, Sangmin
    Ritchie, Ellen K.
    Desai, Pinkal
    Guzman, Monica L.
    Roboz, Gail J.
    Hassane, Duane C.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (04): : 537 - 548
  • [32] MINIMAL RESIDUAL DISEASE ASSESSMENT IN ACUTE MYELOID LEUKEMIA WITH MUTATED NPM1: PROSPECTICAL EVALUATION AND MRD DIRECTED THERAPY
    Guolo, F.
    Minetto, P.
    Clavio, M.
    Di Grazia, C.
    Colombo, N.
    Raiola, A. M.
    Guardo, D.
    Coviello, E.
    Ballerini, F.
    Miglino, M.
    Angelucci, E.
    Bacigalupo, A.
    Lemoli, R. M.
    Gobbi, M.
    HAEMATOLOGICA, 2017, 102 : 47 - 47
  • [33] NPM1 exon 5 mutations in acute myeloid leukemia: Implications in diagnosis and minimal residual monitoring
    Wang, Peng
    Segal, Jeremy
    Drazer, Michael W.
    Venkataraman, Girish
    Arber, Daniel A.
    Gurbuxani, Sandeep
    EJHAEM, 2022, 3 (03): : 962 - 965
  • [34] Sensitive NPM1 Mutation Quantitation in Acute Myeloid Leukemia Using Ultradeep Next-Generation Sequencing in the Diagnostic Laboratory
    Blombery, Piers
    Jones, Kate
    Doig, Ken
    Ryland, Georgina
    McBean, Michelle
    Thompson, Ella
    Yannakou, Costas K.
    Westerman, David
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2018, 142 (05) : 606 - 612
  • [35] Patient-Tailored Analysis of Minimal Residual Disease in Acute Myeloid Leukemia Using Next Generation Sequencing
    Malmberg, Erik
    Stahlman, Sara
    Rehammar, Anna
    Samuelsson, Tore
    Alm, Sofie J.
    Kristiansson, Erik
    Abrahamsson, Jonas
    Garelius, Hege
    Palmqvist, Lars
    Fogelstrand, Linda
    BLOOD, 2015, 126 (23)
  • [36] Elevated HOX gene expression in acute myeloid leukemia is associated with NPM1 mutations and poor survival
    Nagy, Adam
    Osz, Agnes
    Budczies, Jan
    Krizsan, Szilvia
    Szombath, Gergely
    Demeter, Judit
    Bodor, Csaba
    Gyorffy, Balazs
    JOURNAL OF ADVANCED RESEARCH, 2019, 20 : 105 - 116
  • [37] Minimal residual disease (MRD) analysis in acute myeloid leukemia (AML) with normal karyotype carrying NPM1 gene mutations
    Agueli, C.
    La Rosa, M.
    Fabbiano, F.
    Rizzo, V
    Cascio, L.
    Cammarata, G.
    Marfia, A.
    Bica, M. G.
    Mirto, S.
    Santoro, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 169 - 169
  • [38] Next-generation sequencing-defined minimal residual disease before stem cell transplantation predicts acute myeloid leukemia relapse
    Press, Richard D.
    Eickelberg, Garrett
    Froman, Allison
    Yang, Fei
    Stentz, Alex
    Flatley, Ellen M.
    Fan, Guang
    Lim, Jeong Y.
    Meyers, Gabrielle
    Maziarz, Richard T.
    Cook, Rachel J.
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (08) : 902 - 912
  • [39] Monitoring of Minimal Residual Disease in NPM1 Mutated Acute Myeloid Leukemia (AML): Results of the AML Study Group (AMLSG)
    Kroenke, Jan
    Schlenk, Richard
    Jensen, Kai-Ole
    Eiwen, Karina
    Habdank, Marianne
    Spaeth, Daniela
    Krauter, Juergen
    Ganser, Arnold
    Doehner, Hartmut
    Doehner, Konstanze
    BLOOD, 2008, 112 (11) : 260 - 260
  • [40] Assessment of Minimal Residual Disease by NGS in Acute Myeloid Leukemia Patients by Monitoring FLT3 and NPM1 Mutations
    Xie, Z.
    Carson, A. R.
    McClain, V.
    Miller, J. E.
    Levis, M.
    Stenzel, T.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (02): : S10 - S10
12345